Table 10.
Anti-HIV-1 IIIB activity of compounds 333–350.
| Compound No. | R | X | N | EC50 (μM) |
|---|---|---|---|---|
| 333 | H | Cl | 1 | 50.61 ± 0.01 |
| 334 | 6-CH3 | Cl | 1 | 5.54 ± 0.01 |
| 335 | 6-OCH3 | Cl | 1 | 1.96 ± 0.004 |
| 336 | 7-CH3 | Cl | 1 | 0.72 ± 0.007 |
| 337 | 8-CH3 | Cl | 1 | 0.148 ± 0.006 |
| 338 | H | Cl | 2 | 2.92 ± 0.004 |
| 339 | 6-CH3 | Cl | 2 | 22.76 ± 0.002 |
| 340 | 6-OCH3 | Cl | 2 | 1.01 ± 0.01 |
| 341 | 7-CH3 | Cl | 2 | 2.55 ± 0.004 |
| 342 | 7-OCH3 | Cl | 2 | 0.46 ± 0.002 |
| 343 | 7-OCH(CH3)2 | Cl | 2 | 0.33 ± 0.001 |
| 344 | 8-CH3 | Cl | 2 | 0.50 ± 0.004 |
| 345 | H | OCH3 | 1 | 1.41 ± 0.008 |
| 346 | 6-OCH3 | OCH3 | 1 | 0.27 ± 0.003 |
| 347 | H | OCH3 | 2 | 0.42 ± 0.002 |
| 348 | 6-OCH3 | OCH3 | 2 | 1.51 ± 0.002 |
| 349 | – | – | 1 | 1.52 ± 0.004 |
| 350 | – | – | 2 | 1.93 ± 0.005 |
| NB-64 (II) | 2.4 ± 0.008 |
